По вашему запросу найдено документов: 2647
Страница 1 из 265
Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice. The effect of combined immunization with live influenza vaccine and recombinant chimeric pneumococcal protein
Recombinant human adenoviruses as a platform for the creation of new effective and safe vaccines is vaccines based on various viral vectors, including recombinant human adenoviruses. Such vaccines have shown
State of research in the field of the creation of plant vaccines for veterinary use of recombinant proteins for veterinary use are considered, the history of the “edible vaccine” concept is briefly
Vaccine prophylaxis during the covid-19 pandemic. Specific prevention of coronavirus infection technology platforms, including RNA and DNA vaccines, subunit recombinant, live-attenuated and viral vectors
Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine, the immunogenicity and protective properties of three recombinant proteins (vaccine candidates), comprising conserved
Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease children, elderly and immunocompromised adults. There is no licensed vaccine against RSV although
Recombinant viruses for cancer therapy© 2018 by the authors. Recombinant viruses are novel therapeutic agents that can be utilized
Cross-protective properties of an influenza vaccine based on HBc4M2e recombinant protein undergoing clinical trials. We created Uniflu candidate vaccine based on recombinant HBc4M2e protein
Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. Pneumoniae infections infection using an associated vaccine based on live influenza vaccine (LAIV) combined with recombinant
Effectiveness of cross-protective recombinant influenza vaccine based on conserved epitopes of viral proteins M2 and hemagglutinin: to develop the candidate recombinant flu vaccine based on the two conserved influenza proteins (-2 and HA
Страница 1 из 265
Фасеты
Партнеры
Индексация
